Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of PAREXEL International Corporation (NASDAQ: PRXL) acted responsibly on behalf of investors’ profitability in the planned sale to Pamplona Capital Management LLP.

On June 20, 2017, PAREXEL International Corporation (NASDAQ: PRXL) and Pamplona Capital Management LLP announced that they had entered into a merger agreement. Under the terms of the merger agreement, Pamplona will offer PAREXEL shareholders $88.10 per share in cash for all outstanding shares.    

Based in Waltham, Massachusetts, and founded in 1983 PAREXEL International Corporation provides clinical research and logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide.

The investigation is looking to uncover whether PAREXEL International Corporation was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $90.00 per share.

If you purchased PAREXEL International Corporation (NASDAQ: PRXL) prior to June 20, 2017, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185